103 related articles for article (PubMed ID: 12823555)
1. Covalent binding to glutathione of the DNA-alkylating antitumor agent, S23906-1.
David-Cordonnier MH; Laine W; Joubert A; Tardy C; Goossens JF; Kouach M; Briand G; Thi Mai HD; Michel S; Tillequin F; Koch M; Leonce S; Pierre A; Bailly C
Eur J Biochem; 2003 Jul; 270(13):2848-59. PubMed ID: 12823555
[TBL] [Abstract][Full Text] [Related]
2. Design of novel antitumor DNA alkylating agents: the benzacronycine series.
David-Cordonnier MH; Laine W; Gaslonde T; Michel S; Tillequin F; Koch M; Léonce S; Pierré A; Bailly C
Curr Med Chem Anticancer Agents; 2004 Mar; 4(2):83-92. PubMed ID: 15032716
[TBL] [Abstract][Full Text] [Related]
3. Alkylation of guanine in DNA by S23906-1, a novel potent antitumor compound derived from the plant alkaloid acronycine.
David-Cordonnier MH; Laine W; Lansiaux A; Kouach M; Briand G; Pierré A; Hickman JA; Bailly C
Biochemistry; 2002 Aug; 41(31):9911-20. PubMed ID: 12146956
[TBL] [Abstract][Full Text] [Related]
4. Influence of the stereoisomeric position of the reactive acetate groups of the benzo[b]acronycine derivative S23906-1 on its DNA alkylation, helix-opening, cytotoxic, and antitumor activities.
Depauw S; Gaslonde T; Léonce S; Kraus-Berthier L; Laine W; Lenglet G; Chiaroni A; Pfeiffer B; Bailly C; Michel S; Tillequin F; Pierré A; David-Cordonnier MH
Mol Pharmacol; 2009 Dec; 76(6):1172-85. PubMed ID: 19752199
[TBL] [Abstract][Full Text] [Related]
5. A transesterification reaction is implicated in the covalent binding of benzo[b]acronycine anticancer agents with DNA and glutathion.
David-Cordonnier MH; Laine W; Kouach M; Briand G; Vezin H; Gaslonde T; Michel S; Doan Thi Mai H; Tillequin F; Koch M; Léonce S; Pierré A; Bailly C
Bioorg Med Chem; 2004 Jan; 12(1):23-9. PubMed ID: 14697766
[TBL] [Abstract][Full Text] [Related]
6. The NER proteins XPC and CSB, but not ERCC1, regulate the sensitivity to the novel DNA binder S23906: implications for recognition and repair of antitumor alkylators.
Rocca CJ; Poindessous V; Soares DG; Ouadrani KE; Sarasin A; Guérin E; de Gramont A; Henriques JA; Escargueil AE; Larsen AK
Biochem Pharmacol; 2010 Aug; 80(3):335-43. PubMed ID: 20399198
[TBL] [Abstract][Full Text] [Related]
7. BRCA2 is needed for both repair and cell cycle arrest in mammalian cells exposed to S23906, an anticancer monofunctional DNA binder.
Rocca CJ; Soares DG; Bouzid H; Henriques JA; Larsen AK; Escargueil AE
Cell Cycle; 2015; 14(13):2080-90. PubMed ID: 25945522
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, cytotoxic activity, and DNA binding properties of antitumor cis-1,2-dihydroxy-1,2-dihydrobenzo[b]acronycine cinnamoyl esters.
Do Q; Tian W; Yougnia R; Gaslonde T; Pfeiffer B; Pierré A; Léonce S; Kraus-Berthier L; David-Cordonnier MH; Depauw S; Lansiaux A; Mazinghien R; Koch M; Tillequin F; Michel S; Dufat H
Bioorg Med Chem; 2009 Mar; 17(5):1918-27. PubMed ID: 19217791
[TBL] [Abstract][Full Text] [Related]
9. Induction of apoptosis in HL-60 leukemia and B16 melanoma cells by the acronycine derivative S23906-1.
Kluza J; Lansiaux A; Wattez N; Hildebrand MP; Léonce S; Pierré A; Hickman JA; Bailly C
Biochem Pharmacol; 2002 Apr; 63(8):1443-52. PubMed ID: 11996885
[TBL] [Abstract][Full Text] [Related]
10. Protein recognition of the S23906-1-DNA adduct by nuclear proteins: direct involvement of glyceraldehyde-3-phosphate dehydrogenase (GAPDH).
Lenglet G; Depauw S; Mendy D; David-Cordonnier MH
Biochem J; 2013 May; 452(1):147-59. PubMed ID: 23409959
[TBL] [Abstract][Full Text] [Related]
11. Generation of replication-dependent double-strand breaks by the novel N2-G-alkylator S23906-1.
Léonce S; Kraus-Berthier L; Golsteyn RM; David-Cordonnier MH; Tardy C; Lansiaux A; Poindessous V; Larsen AK; Pierré A
Cancer Res; 2006 Jul; 66(14):7203-10. PubMed ID: 16849567
[TBL] [Abstract][Full Text] [Related]
12. Covalent binding of antitumor benzoacronycines to double-stranded DNA induces helix opening and the formation of single-stranded DNA: unique consequences of a novel DNA-bonding mechanism.
David-Cordonnier MH; Laine W; Lansiaux A; Rosu F; Colson P; de Pauw E; Michel S; Tillequin F; Koch M; Hickman JA; Pierré A; Bailly C
Mol Cancer Ther; 2005 Jan; 4(1):71-80. PubMed ID: 15657355
[TBL] [Abstract][Full Text] [Related]
13. Induction of cyclin E and inhibition of DNA synthesis by the novel acronycine derivative S23906-1 precede the irreversible arrest of tumor cells in S phase leading to apoptosis.
Léonce S; Pérez V; Lambel S; Peyroulan D; Tillequin F; Michel S; Koch M; Pfeiffer B; Atassi G; Hickman JA; Pierré A
Mol Pharmacol; 2001 Dec; 60(6):1383-91. PubMed ID: 11723246
[TBL] [Abstract][Full Text] [Related]
14. Protein Recognition in Drug-Induced DNA Alkylation: When the Moonlight Protein GAPDH Meets S23906-1/DNA Minor Groove Adducts.
Savreux-Lenglet G; Depauw S; David-Cordonnier MH
Int J Mol Sci; 2015 Nov; 16(11):26555-81. PubMed ID: 26556350
[TBL] [Abstract][Full Text] [Related]
15. Acronycine derivatives: a promising series of anticancer agents.
Nguyen QC; Nguyen TT; Yougnia R; Gaslonde T; Dufat H; Michel S; Tillequin F
Anticancer Agents Med Chem; 2009 Sep; 9(7):804-15. PubMed ID: 19594412
[TBL] [Abstract][Full Text] [Related]
16. An unusual DNA binding compound, S23906, induces mitotic catastrophe in cultured human cells.
Cahuzac N; Studény A; Marshall K; Versteege I; Wetenhall K; Pfeiffer B; Léonce S; Hickman JA; Pierré A; Golsteyn RM
Cancer Lett; 2010 Mar; 289(2):178-87. PubMed ID: 19758748
[TBL] [Abstract][Full Text] [Related]
17. Structure-activity relationships and mechanism of action of antitumor benzo[b]pyrano[3,2-h]acridin-7-one acronycine analogues.
Thi Mai HD; Gaslonde T; Michel S; Tillequin F; Koch M; Bongui JB; Elomri A; Seguin E; Pfeiffer B; Renard P; David-Cordonnier MH; Laine W; Bailly C; Kraus-Berthier L; Léonce S; Hickman JA; Pierré A
J Med Chem; 2003 Jul; 46(14):3072-82. PubMed ID: 12825945
[TBL] [Abstract][Full Text] [Related]
18. Benzo[b]acronycine derivatives: a novel class of antitumor agents.
Michel S; Gaslonde T; Tillequin F
Eur J Med Chem; 2004 Aug; 39(8):649-55. PubMed ID: 15276298
[TBL] [Abstract][Full Text] [Related]
19. Lack of a role of glutathione in cellular nonenzymatic activation of BMS-181174, a novel analogue of mitomycin C.
Xia H; Pinto T; Hu X; Benson PJ; Zaren HA; Gupta V; Singh S
Cancer Res; 1996 Aug; 56(15):3495-8. PubMed ID: 8758917
[TBL] [Abstract][Full Text] [Related]
20. Acronycine derivatives as promising antitumor agents.
Guilbaud N; Léonce S; Tillequin F; Koch M; Hickman JA; Pierré A
Anticancer Drugs; 2002 Jun; 13(5):445-9. PubMed ID: 12045455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
